MXPA05007853A - Antagonistas de il-1 beta humana. - Google Patents
Antagonistas de il-1 beta humana.Info
- Publication number
- MXPA05007853A MXPA05007853A MXPA05007853A MXPA05007853A MXPA05007853A MX PA05007853 A MXPA05007853 A MX PA05007853A MX PA05007853 A MXPA05007853 A MX PA05007853A MX PA05007853 A MXPA05007853 A MX PA05007853A MX PA05007853 A MXPA05007853 A MX PA05007853A
- Authority
- MX
- Mexico
- Prior art keywords
- antigen
- human
- binding portions
- antibodies
- beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/245—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Abstract
La presente invencion abarca anticuerpos aislados, o sus porciones de union a antigeno, que especificamente unen IL-1 beta humano maduro. Estos anticuerpos, o sus porciones de union a antigeno, generalmente exhiben altas afinidades de union (valores de Kooff bajos), desamidacion reducida, comparado con el anticuerpo nativo, y se pueden utilizar para tratar varios trastornos tales como artritis reumatoide, osteoartritis, o neuroinflamacion.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44279803P | 2003-01-24 | 2003-01-24 | |
PCT/US2004/000019 WO2004067568A2 (en) | 2003-01-24 | 2004-01-21 | Human il-1 beta antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05007853A true MXPA05007853A (es) | 2006-02-10 |
Family
ID=32825261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05007853A MXPA05007853A (es) | 2003-01-24 | 2004-01-21 | Antagonistas de il-1 beta humana. |
Country Status (9)
Country | Link |
---|---|
US (2) | US7541033B2 (es) |
EP (1) | EP1590369B1 (es) |
JP (2) | JP4538461B2 (es) |
CN (1) | CN1780855B (es) |
AU (1) | AU2004207741B2 (es) |
CA (1) | CA2509136C (es) |
ES (1) | ES2567198T3 (es) |
MX (1) | MXPA05007853A (es) |
WO (1) | WO2004067568A2 (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7541033B2 (en) * | 2003-01-24 | 2009-06-02 | Applied Molecular Evolution, Inc. | Humanized anti-IL-1β antibodies |
US7566772B2 (en) | 2005-01-26 | 2009-07-28 | Amgen Fremont Inc. | Antibodies against interleukin-1β |
EP2322552B1 (en) | 2005-06-21 | 2016-02-10 | Xoma (Us) Llc | IL-1beta binding antibodies and fragments thereof |
SI1940465T1 (sl) * | 2005-10-26 | 2012-10-30 | Novartis Ag | Nova uporaba protiteles proti IL-1 beta |
WO2008061160A1 (en) * | 2006-11-14 | 2008-05-22 | Pharmacyclics, Inc. | Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions |
CN103405768A (zh) | 2006-12-20 | 2013-11-27 | 爱克索马技术有限公司 | 用于治疗IL-1β相关疾病的方法 |
DK2391650T3 (en) | 2007-12-20 | 2015-01-12 | Xoma Us Llc | Methods of treating gout |
CA2735939A1 (en) | 2008-09-05 | 2010-03-11 | Xoma Technology Ltd. | Methods for improvement of beta cell function |
US8383778B2 (en) * | 2009-01-29 | 2013-02-26 | Abbvie Inc. | IL-1 binding proteins |
EP2455097B1 (en) | 2009-07-16 | 2016-02-17 | Sunstar Inc. | Proteoglycan-containing material |
IN2015DN02826A (es) | 2009-09-03 | 2015-09-11 | Merck Sharp & Dohme | |
MX2012004412A (es) * | 2009-10-15 | 2012-05-08 | Abbott Lab | Proteinas de union a il-1. |
BR112012010707B1 (pt) * | 2009-11-04 | 2022-08-30 | Merck Sharp & Dohme Corp | Anticorpo ou fragmento de ligação ao antígeno do mesmo, composição, e, uso do anticorpo ou fragmento de ligação ao antígeno do mesmo |
CN102883748A (zh) | 2010-05-07 | 2013-01-16 | 爱克索马技术有限公司 | 治疗IL-1β相关状况的方法 |
EP2614085B1 (en) * | 2010-09-10 | 2016-04-20 | Apexigen, Inc. | Anti-il-1 beta antibodies and methods of use |
JP6071558B2 (ja) | 2011-01-19 | 2017-02-01 | 国立大学法人弘前大学 | プロテオグリカンの大量調製法 |
TW201527322A (zh) * | 2011-02-08 | 2015-07-16 | Abbvie Inc | 骨關節炎及疼痛之治療 |
EP3150632B1 (en) * | 2011-06-10 | 2020-04-08 | Her Majesty The Queen in right of Canada, as represented by the Minister of National Defence | Anti-ricin antibodies and uses thereof |
EP3050900A1 (en) | 2011-12-19 | 2016-08-03 | Xoma (Us) Llc | Methods for treating acne |
CN105431452B (zh) | 2012-02-13 | 2019-12-31 | 新加坡科技研究局 | 中和IL-1β的人单克隆抗体 |
ES2769850T3 (es) * | 2012-07-25 | 2020-06-29 | Univ Hirosaki | Composición para prevenir o tratar la osteoartrosis |
CN103588878A (zh) * | 2012-08-15 | 2014-02-19 | 江苏泰康生物医药有限公司 | 一种人源化抗人白细胞介素1 β单克隆抗体及其制备与应用 |
US9404930B2 (en) * | 2012-11-05 | 2016-08-02 | Delenex Therapeutics Ag | Antibody to human IL-1 beta |
ES2895848T3 (es) * | 2012-12-17 | 2022-02-22 | Cell Medica Inc | Anticuerpos contra IL-1 beta |
WO2016008851A1 (en) * | 2014-07-14 | 2016-01-21 | Boehringer Ingelheim International Gmbh | Anti-il-1b antibodies |
CN107074942A (zh) * | 2014-11-10 | 2017-08-18 | 豪夫迈·罗氏有限公司 | 抗‑IL‑1β抗体和使用方法 |
BR112017009764A2 (pt) | 2014-11-10 | 2018-02-20 | Hoffmann La Roche | anticorpos biespecíficos e métodos de uso em oftalmologia |
AU2015345322A1 (en) | 2014-11-10 | 2017-04-06 | F. Hoffmann-La Roche Ag | Anti-PDGF-B antibodies and methods of use |
CN107001456A (zh) | 2014-11-10 | 2017-08-01 | 豪夫迈·罗氏有限公司 | 抗ang2 抗体及使用方法 |
JOP20180021A1 (ar) * | 2017-03-16 | 2019-01-30 | Janssen Biotech Inc | الأجسام المضادة لتكتلات خيوط بروتين تاو (tau) الحلزونية المزدوجة واستخداماتها |
CN110818793A (zh) * | 2018-08-14 | 2020-02-21 | 中山康方生物医药有限公司 | 抗IL-1β的抗体、其药物组合物及其用途 |
CN111217912B (zh) * | 2018-11-26 | 2022-11-08 | 东莞市朋志生物科技有限公司 | 一种抗pgⅱ的抗体及其应用 |
TWI793503B (zh) | 2020-01-20 | 2023-02-21 | 美商美國禮來大藥廠 | 抗IL-1β抗體 |
WO2022167916A1 (en) * | 2021-02-03 | 2022-08-11 | Novartis Ag | Use of il-1b binding antibodies for treating neuroinflammatory disorders |
US20230227545A1 (en) * | 2022-01-07 | 2023-07-20 | Johnson & Johnson Enterprise Innovation Inc. | Materials and methods of il-1beta binding proteins |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0569687B1 (en) * | 1984-05-18 | 2002-08-21 | New England Medical Center Hospitals, Inc. | Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins |
US5484887A (en) * | 1984-06-19 | 1996-01-16 | Immunex Corporation | Homogeneous interleukin 1 |
US5225539A (en) * | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
US4935343A (en) * | 1986-08-08 | 1990-06-19 | Syntex (U.S.A.) Inc. | Monoclonal antibodies for interleukin-1β |
WO1990005144A1 (en) * | 1988-11-11 | 1990-05-17 | Medical Research Council | Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
WO1994004679A1 (en) * | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
WO1995001997A1 (en) * | 1993-07-09 | 1995-01-19 | Smithkline Beecham Corporation | RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN |
US5681993A (en) * | 1994-04-18 | 1997-10-28 | Heitman; Lynn Byron | Method and apparatus for measuring grip force |
EP2289550A3 (en) * | 2000-01-27 | 2012-02-15 | MedImmune, LLC | Ultra high affinity neutralizing antibodies |
AU2001240020B9 (en) * | 2000-03-01 | 2008-12-04 | Medimmune, Llc | High potency recombinant antibodies and method for producing them |
GB0020685D0 (en) * | 2000-08-22 | 2000-10-11 | Novartis Ag | Organic compounds |
EP1423432A4 (en) | 2001-07-26 | 2006-01-11 | Lilly Co Eli | ANTIBODIES TO INTERLEUKIN 1 BETA (IL-1BETA) |
AU2003208946A1 (en) * | 2002-02-28 | 2003-09-16 | Eli Lilly And Company | Anti-interleukin-1 beta analogs |
US7541033B2 (en) * | 2003-01-24 | 2009-06-02 | Applied Molecular Evolution, Inc. | Humanized anti-IL-1β antibodies |
-
2004
- 2004-01-21 US US10/542,508 patent/US7541033B2/en active Active
- 2004-01-21 MX MXPA05007853A patent/MXPA05007853A/es active IP Right Grant
- 2004-01-21 EP EP04703964.9A patent/EP1590369B1/en not_active Expired - Lifetime
- 2004-01-21 WO PCT/US2004/000019 patent/WO2004067568A2/en active Search and Examination
- 2004-01-21 JP JP2006536490A patent/JP4538461B2/ja not_active Expired - Fee Related
- 2004-01-21 CA CA2509136A patent/CA2509136C/en not_active Expired - Fee Related
- 2004-01-21 CN CN2004800027028A patent/CN1780855B/zh not_active Expired - Fee Related
- 2004-01-21 ES ES04703964.9T patent/ES2567198T3/es not_active Expired - Lifetime
- 2004-01-21 AU AU2004207741A patent/AU2004207741B2/en not_active Ceased
-
2009
- 2009-04-23 US US12/428,558 patent/US7714120B2/en not_active Expired - Lifetime
-
2010
- 2010-01-04 JP JP2010000085A patent/JP2010143929A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2004067568A3 (en) | 2004-10-07 |
US20090209004A1 (en) | 2009-08-20 |
US20060140932A1 (en) | 2006-06-29 |
AU2004207741B2 (en) | 2011-02-10 |
JP2010143929A (ja) | 2010-07-01 |
EP1590369B1 (en) | 2016-03-16 |
ES2567198T3 (es) | 2016-04-20 |
CA2509136C (en) | 2013-10-29 |
AU2004207741A1 (en) | 2004-08-12 |
CN1780855B (zh) | 2011-03-30 |
US7714120B2 (en) | 2010-05-11 |
US7541033B2 (en) | 2009-06-02 |
JP2007531509A (ja) | 2007-11-08 |
CA2509136A1 (en) | 2004-08-12 |
JP4538461B2 (ja) | 2010-09-08 |
WO2004067568A2 (en) | 2004-08-12 |
CN1780855A (zh) | 2006-05-31 |
EP1590369A2 (en) | 2005-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05007853A (es) | Antagonistas de il-1 beta humana. | |
EP1461081A4 (en) | ANTI-CD45RB ANTIBODY FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AND TRANSPLANT ABLUSION | |
MX2010003574A (es) | Anticuerpos il-23. | |
EA200870050A1 (ru) | Анти-il-17-антитела | |
ZA200806610B (en) | Anti-IL-6 antibodies preventing the binding of IL-6 complexed with IL-6ralpha to GP130 | |
IL222756A0 (en) | Antibodies and antigen-binding fragments thereof that bind to a sclerostin polypeptide, compositions containing the same and methods for the production thereof | |
WO2005012493A3 (en) | Anti-cd19 antibodies | |
MY144612A (en) | Nogo-a neutralising immunoglobulins for treatment of neurological diseases | |
AU2003215188A8 (en) | Fusion proteins of humanized g250 specific antibodies and uses thereof | |
TW200714290A (en) | Anti-M-CSF antibody compositions having reduced levels of endotoxin | |
HK1119712A1 (en) | Anti-il-23 antibodies | |
TW200709817A (en) | Platform antibody compositions | |
TW200503721A (en) | Aminoquinoline compounds | |
MX2009008104A (es) | Hepcidina, antagonistas de hepcidina y metodos de uso. | |
RS28904A (en) | Angiopoietin-2 specific binding agents | |
CR9599A (es) | Proteinas de union a il-12/p40 | |
MX2009001110A (es) | Anticuerpos monoclonales anti-il-6 y usos de los mismos. | |
NO20083053L (no) | Humane monoklonale antistoffer mot O8E | |
HK1116803A1 (en) | Novel anti-plgf antibody | |
NO20083062L (no) | Humane monoklonale antistoffer mot fukosyl-GM1 og fremgangsmater for anvendelse av anti-fukosyl-GM1 | |
UA89017C2 (uk) | ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b | |
MY149492A (en) | Immunoglobulins directed against nogo | |
DK1572087T3 (da) | Antistoffer med cancerantigen TMEFF2 og anvendelser deraf | |
MY149858A (en) | Rodent pest control | |
SG162829A1 (en) | Humanised antibodies specific for nogo-a and pharmaceutical uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |